company background image
CSBR

Champions Oncology NasdaqCM:CSBR Stock Report

Last Price

US$4.05

Market Cap

US$54.9m

7D

-0.7%

1Y

-48.1%

Updated

27 Jan, 2023

Data

Company Financials +

Champions Oncology, Inc.

NasdaqCM:CSBR Stock Report

Mkt Cap: US$54.9m

CSBR Stock Overview

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States.

CSBR fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Champions Oncology, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Champions Oncology
Historical stock prices
Current Share PriceUS$4.05
52 Week HighUS$9.88
52 Week LowUS$3.75
Beta0.98
1 Month Change-6.25%
3 Month Change-42.80%
1 Year Change-48.08%
3 Year Change-46.64%
5 Year Change12.50%
Change since IPO-66.25%

Recent News & Updates

Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Sep 28
Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Recent updates

Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Sep 28
Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation

Oct 14
We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation

We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth

Jun 21
We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth

Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?

Apr 09
Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?

Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation

Mar 19
Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation

The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?

Mar 02
The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?

Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?

Feb 04
Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?

Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?

Jan 14
Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?

Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares

Dec 19
Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares

Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results

Dec 16
Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results

Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)

Dec 04
Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)

Shareholder Returns

CSBRUS Life SciencesUS Market
7D-0.7%-1.1%2.3%
1Y-48.1%-9.3%-9.7%

Return vs Industry: CSBR underperformed the US Life Sciences industry which returned -6.9% over the past year.

Return vs Market: CSBR underperformed the US Market which returned -8.5% over the past year.

Price Volatility

Is CSBR's price volatile compared to industry and market?
CSBR volatility
CSBR Average Weekly Movement15.6%
Life Sciences Industry Average Movement11.8%
Market Average Movement6.9%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market2.9%

Stable Share Price: CSBR is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 16% a week.

Volatility Over Time: CSBR's weekly volatility has increased from 9% to 16% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1985230Ronnie Morrishttps://www.championsoncology.com

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice.

Champions Oncology, Inc. Fundamentals Summary

How do Champions Oncology's earnings and revenue compare to its market cap?
CSBR fundamental statistics
Market CapUS$54.91m
Earnings (TTM)US$108.00k
Revenue (TTM)US$54.10m

508.4x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CSBR income statement (TTM)
RevenueUS$54.10m
Cost of RevenueUS$27.12m
Gross ProfitUS$26.97m
Other ExpensesUS$26.87m
EarningsUS$108.00k

Last Reported Earnings

Oct 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.008
Gross Margin49.86%
Net Profit Margin0.20%
Debt/Equity Ratio0%

How did CSBR perform over the long term?

See historical performance and comparison